Subscribe To
AURA / Why Shares of Aura Biosciences Jumped This Week
AURA News
By The Motley Fool
February 10, 2023
Why Shares of Aura Biosciences Jumped This Week
The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy. more_horizontal
By Benzinga
July 19, 2022
JMP Is Bullish On This Cancer Stock "Sees New Way to Treat Cancer"
JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ: AURA) with a Market Outperform rating and a $26 risk-adjusted price ta more_horizontal